GFM Network News


Elanco gets EU’s conditional antitrust OK for Bayer deal

Approval calls for sale of Vecoxan brand, among others

Reuters/Staff — Elanco Animal Health secured antitrust clearance on Monday from the European Union to buy Bayer’s veterinary drugs unit, after pledging to sell some products to address competition concerns about the US$7.6 billion deal. The European Commission said the companies will sell either Elanco or Bayer’s products or those in the pipeline, including licenses, […] Read more